Award NoticePosted Jan 8, 2026

FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

FDA · FDA Office of Acquisitions and Grants Services

Stage
Awarded
NAICS
541714
Value
$15.7M
Solicitation
FDABAA-25-00123_Award
Set-aside
None stated
PSC
AJ11
Place
Silver Spring, MD, USA
Contact
Ian Weiss (Ian.Weiss@fda.hhs.gov)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation FDABAA-25-00123_Award in this department, oldest first.

Early notice
None posted
Solicitation
None posted
Award
  • Nov 24, 2025
    Award Notice
    Please_see_Spreadsheet Silver Spring MD 20993 USA · $15.7M
    Open
  • Jan 8, 2026 · this notice
    Award Notice
    Please_see_Spreadsheet Silver Spring MD 20993 USA · $15.7M
  • Jan 8, 2026
    Award Notice
    Please_see_Spreadsheet Silver Spring MD 20993 USA · $15.7M
    Open
  • Jan 13, 2026
    Award Notice
    Please_see_Spreadsheet Silver Spring MD 20993 USA · $16.7M
    Open

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Note the winner and the end of the period of performance for the recompete.
  • Follow the agency to see the next notice for this work.

What the notice says

Please see attached Spreadsheet for all contracts awarded in this oppertunity. A total of 13 Contracts were awarded in FY23 from this BAA Announcement.

Who won similar work

22 award notices on SAM.gov in the last 24 months. Match: Same agency (FDA), any industry: a loose match.

Loose match: same agency, any industry. Read the titles before treating these as competitors.

WinnerAwardsValueLast
Please_See_Spreadsheet Silver Spring MD 20993 USA1$120.8MOct 8, 2026
DCT, INCORPORATED1$52.8MSep 15, 2026
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC1$50.0MSep 16, 2025
NATI-NVE Support Services, LLC1$49.0MMay 21, 2026
HARVARD PILGRIM HEALTH CARE INC1$31.7MMar 30, 2026
TOXICOLOGIC PATHOLOGY ASSOCIATES INC1$26.1MSep 15, 2025
IHRC, INCORPORATED1$14.5MSep 16, 2026
VITALANT Scottsdale AZ 85258 USA1$10.0MSep 8, 2025
WE PHARMA, INC.1$4.0MSep 11, 2026
THE BIONETICS CORP1$2.8MJul 21, 2025

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Food & Drug Administration (FDA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Food & Drug Administration (FDA) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 129 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.